Golden Biotechnology Corporation operates as a drug discovery and healthy food supplement manufacturing company in Taiwan, the United States, Japan, China, Korea, and Singapore. Its products include Liverty that is used for liver health support and fatigue; Rasle, an auto-immune adjuvant therapy; ZSAINO, a nourishment product for recovery from illness and for health improvement; and UMOOZE, a herbal formula for optimal health in males. The company also provides Antroquinonol, an anticancer molecule for the treatment of pancreatic cancer, acute myeloid leukemia, and hepatocellular carcinoma, as well as hypercholesterolemia and hyperlipidemia. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
Stock data | 2024 | Change |
---|---|---|
Price | $0.47314554508204254 | N/A |
Market Cap | $67.29M | N/A |
Shares Outstanding | 142.23M | N/A |
Employees | 0 | N/A |